A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

Arthritis and Rheumatism

Volumn 39, Issue 11, 1996, Pages 1852-1859

  Goldenberg, Don ^a,c   Mayskiy, Michael ^a   Mossey, Christopher ^a   Ruthazer, Robin ^b   Schmid, Christopher ^b  

^a NEWTON WELLESLEY HOSPITAL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; FLUOXETINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; MALE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; WELLBEING;

ADOLESCENT; ADULT; AMITRIPTYLINE; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FIBROMYALGIA; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0029956785     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391111     Document Type: Article

References (29)

1. Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study. Arthritis Rheum 29:655-659, 1986
2. Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29:1371-1377, 1986
3. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 18:447-451, 1991
4. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind controlled study. Arthritis Rheum 31:1535-1542, 1988
5. Reynolds WJ, Moldofsky H, Saskin P, Lue FA: The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 18:452-454, 1991
6. Quimby LG, Gratwick GM, Whitney CD, Block SR: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol (suppl 16) 19:140-143, 1989
7. Caruso I, Sarzi Puttini PC, Boccassini L, Santandrea S, Locati M, Volpato R, Montrone F, Benvenuti C, Beretta A: Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 15:154-159, 1987
8. Wysenbeek AJ, Mor F, Lurie Y, Weinberger A: Imipramine for the treatment of fibrositis: a therapeutic trial. Ann Rheum Dis 44:752-753, 1985
9. Carette J, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG, Bellamy N, Guimont C: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 37:32-40, 1994
10. Geller SA: Treatment of fibrositis with fluoxetine hydrochloride (Prozac). Am J Med 87:594-595, 1989
11. Wolfe F, Cathey MA, Hawley DJ: A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23:255-259, 1994
12. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172, 1990
13. Burckhardt CS, Clark SR, Bennett RM: The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728-733, 1991
14. Kaplan KH, Goldenberg DL, Galvin-Nadeau M: The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry 15:284-289, 1993
15. Senn S: Crossover Trials in Clinical Research. New York, Wiley, 1993
16. Little RJA, Ruhin DB: Statistical Analysis with Missing Data. New York, Wiley, 1987
17. SAS Institute, Inc.: SAS/STAT Software. Cary, NC, SAS Institute, Inc., 1989
18. Simms RW, Felson DT, Goldenberg DL: Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 18:1558-1563, 1991
19. Croft P, Scholium J, Silman A: Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 309:696-699, 1994
20. Urrows S, Affleck G, Tennen H, Higgins P: Unique clinical and psychological correlates of fibromyalgia tender points and joint tenderness in rheumatoid arthritis. Arthritis Rheum 37:1513-1520, 1994
21. Jocobs JWG, Rasker JJ, van der Heide A, Boersma JW, de Blecourt ACE, Griep EN, van Rijswijk MH, Bijlsma JWJ: Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia. Arthritis Care Res 9:105-111, 1996
22. Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35:550-556, 1992
23. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE. Lopez Y, MacKillip F: Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37:1593-1601, 1994
24. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19:104-109, 1992
25. Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of somatomedin-C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 35:1113-1116, 1992
26. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL: Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37:1583-1592, 1994
27. Griep EN, Boersma JW, de Kloet ER: Pituitary release of growth hormone and prolactin in primary FS. J Rheumatol 21:2125-2130, 1994
28. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256, 1992
29. Carette S, Oakson G, Guimont C, Steriade M: Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 38:1211-1217, 1995